Cerevel Therapeutics Holdings CERE

$ 44.96 0.0%

Quarterly report 2024-Q1
added 05-08-2024

Cerevel Therapeutics Holdings EV/EBITDA Ratio 2011-2024 | CERE

Annual EV/EBITDA Ratio Cerevel Therapeutics Holdings

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-19.7	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-19.7	-19.7	-19.7